El Hospital Base San José de Osorno es el principal recinto hospitalario de la provincia de Osorno, Chile. Ubicado en la capital de la provincia, es un hospital de tipo público de alta complejidad perteneciente al Servicio de Salud Osorno.

During the past decade, Hospital Base Osorno conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Base Osorno" #1 sponsor was "Amgen" with 1 trials, followed by "Children's & Women's Health Centre of British Columbia" with 1 trials sponsored, "Genova Inc." with 1 trials sponsored, "University of Alberta" with 1 trials sponsored and "University of British Columbia" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Base Osorno" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator and "Sunnybrook Research Institute" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Base Osorno" are "COVID-19" (1 trials), "Covid19" (1 trials), "Diabetes" (1 trials), "Gestational Hypertension" (1 trials) and "Heart Failure" (1 trials). Many other conditions were trialed in "Hospital Base Osorno" in a lesser frequency.

Most popular intervention types in "Hospital Base Osorno" are "Biological" (1 trials), "Drug" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Apremilast" (1 trials), "Apremilast placebo" (1 trials), "Intervention is blood pressure management approach" (1 trials), "Intervention is blood pressure management approach." (1 trials) and "Lanadelumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Base Osorno" are 4 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Base Osorno". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Hospital Base Osorno, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Base Osorno, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".